Atlas Trials

Five Year Study to Track Use of DecisionDX-Melanoma Test in Patients With Cutaneous Melanoma and Associated Patient Outcomes

Clinical trial NCT02355587 · TERMINATED

Trial details

NCT number
NCT02355587
Sponsor
Castle Biosciences Incorporated
Status
TERMINATED
Study type
OBSERVATIONAL
Cutaneous Melanoma
Start date
2014-03-01
Primary completion
2021-07-01
Enrollment
72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.